Healthcare provider profile · identity verified

Connor Whitaker, MD

Family Practice · PHILADELPHIA, PA · NPI 1427686344

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	173
Albuterol Sulfate Hfa	Albuterol Sulfate	475	172
Amlodipine Besylate	Amlodipine Besylate	445	153
Pantoprazole Sodium	Pantoprazole Sodium	286	107
Furosemide	Furosemide	285	87
Losartan Potassium	Losartan Potassium	282	88
Gabapentin	Gabapentin	275	104
Prednisone	Prednisone	268	145
Lisinopril	Lisinopril	253	90
Metoprolol Succinate	Metoprolol Succinate	238	78
Carvedilol	Carvedilol	229	67
Fluticasone Propionate	Fluticasone Propionate	204	93
Metformin Hcl	Metformin Hcl	183	55
Rosuvastatin Calcium	Rosuvastatin Calcium	182	56
Tizanidine Hcl	Tizanidine Hcl	170	98
Hydrochlorothiazide	Hydrochlorothiazide	159	56
Tamsulosin Hcl	Tamsulosin Hcl	152	57
Diclofenac Sodium	Diclofenac Sodium	140	70
Omeprazole	Omeprazole	138	43
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	121	51
Montelukast Sodium	Montelukast Sodium	117	49
Azithromycin	Azithromycin	115	79
Spironolactone	Spironolactone	112	28
Clopidogrel	Clopidogrel Bisulfate	111	27
Ibuprofen	Ibuprofen	109	49
Trazodone Hcl	Trazodone Hcl	107	49
Farxiga	Dapagliflozin Propanediol	103	24
Ozempic	Semaglutide	97	24
Levothyroxine Sodium	Levothyroxine Sodium	93	27
Allopurinol	Allopurinol	91	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	91	72
Mirtazapine	Mirtazapine	91	26
Oxycodone Hcl	Oxycodone Hcl	91	22
Eliquis	Apixaban	88	26
Entresto	Sacubitril/Valsartan	78	16
Bumetanide	Bumetanide	70	26
Duloxetine Hcl	Duloxetine Hcl	70	34
Triamcinolone Acetonide	Triamcinolone Acetonide	70	41
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	19
Simvastatin	Simvastatin	68	19
Glipizide	Glipizide	64	20
Hydralazine Hcl	Hydralazine Hcl	64	17
Meloxicam	Meloxicam	64	37
Alendronate Sodium	Alendronate Sodium	63	20
Ammonium Lactate	Ammonium Lactate	58	19
Jardiance	Empagliflozin	58	19
Nifedipine Er	Nifedipine	57	23
Trulicity	Dulaglutide	57	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	17
Meclizine Hcl	Meclizine Hcl	55	25
Baclofen	Baclofen	54	20
Famotidine	Famotidine	53	23
Metoprolol Tartrate	Metoprolol Tartrate	53	22
Quetiapine Fumarate	Quetiapine Fumarate	52	16
Potassium Chloride	Potassium Chloride	51	19
Metformin Hcl Er	Metformin Hcl	50	13
Colchicine	Colchicine	49	20
Citalopram Hbr	Citalopram Hydrobromide	48	20
Escitalopram Oxalate	Escitalopram Oxalate	48	suppressed
Valsartan	Valsartan	45	17
Atenolol	Atenolol	42	suppressed
Incruse Ellipta	Umeclidinium Bromide	42	suppressed
Cilostazol	Cilostazol	41	suppressed
Latanoprost	Latanoprost	41	15
Ezetimibe	Ezetimibe	40	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	13
Alcohol Prep Pads	Alcohol Antiseptic Pads	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	23
Xarelto	Rivaroxaban	37	13
Pravastatin Sodium	Pravastatin Sodium	36	13
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	35	suppressed
Ketoconazole	Ketoconazole	35	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	16
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Topiramate	Topiramate	32	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	31	suppressed
Clobetasol Propionate	Clobetasol Propionate	31	16
Donepezil Hcl	Donepezil Hcl	31	suppressed
Levofloxacin	Levofloxacin	31	21
Tramadol Hcl	Tramadol Hcl	30	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Loperamide	Loperamide Hcl	28	11
Glipizide-Metformin	Glipizide/Metformin Hcl	27	suppressed
Hydrocortisone	Hydrocortisone	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	suppressed
Methotrexate	Methotrexate Sodium	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	11
Torsemide	Torsemide	25	suppressed
Lorazepam	Lorazepam	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Diazepam	Diazepam	20	suppressed
Naproxen	Naproxen	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Finasteride	Finasteride	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	19	18
Warfarin Sodium	Warfarin Sodium	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Fluconazole	Fluconazole	17	15
Glipizide Er	Glipizide	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nitroglycerin	Nitroglycerin	16	14
Procto-Med Hc	Hydrocortisone	16	suppressed
Risperidone	Risperidone	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Fentanyl	Fentanyl	15	suppressed
Nystatin	Nystatin	15	suppressed
Santyl	Collagenase Clostridium Hist.	15	suppressed
Single Use Swab	Alcohol Antiseptic Pads	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Metronidazole	Metronidazole	13	12
Desloratadine	Desloratadine	12	suppressed
Lactulose	Lactulose	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Mounjaro	Tirzepatide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Carvedilol Er	Carvedilol Phosphate	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Digoxin	Digoxin	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Sulfasalazine Dr	Sulfasalazine	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error